B.C.'s Applied Biologicals Commercializes R&D With Government Support
Applied Biological Materials Inc. of British Columbia has succeeded in commercializing a new detection system for genetic information.
Location Canada 2011
The company has developed a microRNA (miRNA) expression and detection system where miRNA is known to regulate the genome, which is the basic foundation for human health and medical conditions. The system is used in life science research and biotechnology industries across Canada and the world.
"Research in miRNA holds great promise for the life science community and can ultimately contribute to innovative diagnostic assays and therapeutic modalities. Through government of Canada support, Applied Biological Materials Inc. has been elevated to become one of the world's top players in this technology," said CEO Dr. Peter Li. "Our dominant position has opened and will continue to open new job opportunities in Canada. In short, it is almost impossible for Applied Biological Materials Inc. to take on cutting-edge research and development, like the miRNA project, without the government's support."
Project Announcements
South Korea-Based Hanon Systems Plans Woodbridge, Ontario, Manufacturing Operations
11/09/2024
OmniaBio Plans Hamilton, Ontario, Manufacturing Operations
10/30/2024
Jungbunzlauer Expands Port Colborne, Ontario, Production Operations
10/14/2024
Bartlett Group Plans Strathcona County, Alberta, Headquarters-Manufacturing Operations
10/11/2024
Golden Windows Expands Kitchener, Ontario, Operations
09/06/2024
The Goodyear Tire & Rubber Company Expands Napanee, Ontario, Operations
08/13/2024
Most Read
-
How Automation Is Actually Closing the Labor Gap
Q4 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
The Role of Rail in Industrial Development
Q4 2024
-
Hydrogen Industry in Canada: A Global Leader in the Clean Energy Revolution
Q3 2024
-
Which AI Tools Work for Job Recruiters?
Q3 2024
-
Permitted Power Capacity Foreshadows Health of Regional Economies
Q3 2024
-
Navigating Non-Disclosure Agreements in Site Selection
Q3 2024